CoChat

Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions

Open access
Myint, Melissa, Oppedisano, Francesca, De Giorgi, Valeria, Kim, Byeong-Moo, Marincola, Francesco M., Alter, Harvey J., Nesci, Salvatore · 2023 · Journal of Translational Medicine

The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.

Abstract

Liver steatosis, inflammation, and variable degrees of fibrosis are the pathological manifestations of nonalcoholic steatohepatitis (NASH), an aggressive presentation of the most prevalent chronic liver disease in the Western world known as nonalcoholic fatty liver (NAFL). Mitochondrial hepatocyte dysfunction is a primary event that triggers inflammation, affecting Kupffer and hepatic stellate cell behaviour. Here, we consider the role of impaired mitochondrial function caused by lipotoxicity during oxidative stress in hepatocytes. Dysfunction in oxidative phosphorylation and mitochondrial ROS production cause the release of damage-associated molecular patterns from dying hepatocytes, leading to activation of innate immunity and trans-differentiation of hepatic stellate cells, thereby driving fibrosis in NASH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12967-023-04627-0

Cites

128 of 128 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 NAFL spectrum during development and progression. In healthy livers, fat accumulation in hepatocytes develops a non-alcoholic fatty liver (NAFL) that can progress from steatosis to a more severe form of steatohepatitis (NASH) characterized by inflammation and fibrosis. In most cases, but not all, NASH can be reversed to less severe disease through changes in lifestyle and diet. Continued fibrogenesis, however, drives progression of NASH to a state of irreversibility, eventually leading to cirrhosis and even hepatocellular carcinoma in some cases
Fig. 1 NAFL spectrum during development and progression. In healthy livers, fat accumulation in hepatocytes develops a non-alcoholic fatty liver (NAFL) that can progress from steatosis to a more severe form of steatohepatitis (NASH) characterized by inflammation and fibrosis. In most cases, but not all, NASH can be reversed to less severe disease through changes in lifestyle and diet. Continued fibrogenesis, however, drives progression of NASH to a state of irreversibility, eventually leading to cirrhosis and even hepatocellular carcinoma in some casesCC BY · PubMed Central
Fig. 2 Liver inflammatory processes under conditions of oxidative stress in impaired mitochondria. Mitochondrial dysfunction triggers ROS production in OXPHOS. The damaged mtDNA formed under stress conditions is released into the cytosol, triggering certain inflammatory processes. NRLP3 inflammasome activation, TLR9 signaling, and activation of the cGAS-STING pathway generate inflammatory mediators, such as cytokines, including interferons, or IFNs. OXPHOS oxidative phosphorylation, OGG1 8-oxoguanine DNA glycosylase-1, FEN1 Flap Structure-Specific Endonuclease 1, VDAC voltage-dependent anion channel, IMM and OMM inner and outer mitochondrial membrane, respectively, NRLP3 NLR Family Pyrin Domain Containing 3, IL interleukin, Cas-1 caspase 1, TLR9 toll-like receptor 9, MyD88 myeloid differentiation primary response 88, cGAS cyclic GMP–AMP synthase, cGAMP cyclic guanosine monophosphate–adenosine, STING stimulator of interferon genes, IRF3 interferon regulatory factor 3. Figure created with BioRender (http://www.BioRender.com)
Fig. 2 Liver inflammatory processes under conditions of oxidative stress in impaired mitochondria. Mitochondrial dysfunction triggers ROS production in OXPHOS. The damaged mtDNA formed under stress conditions is released into the cytosol, triggering certain inflammatory processes. NRLP3 inflammasome activation, TLR9 signaling, and activation of the cGAS-STING pathway generate inflammatory mediators, such as cytokines, including interferons, or IFNs. OXPHOS oxidative phosphorylation, OGG1 8-oxoguanine DNA glycosylase-1, FEN1 Flap Structure-Specific Endonuclease 1, VDAC voltage-dependent anion channel, IMM and OMM inner and outer mitochondrial membrane, respectively, NRLP3 NLR Family Pyrin Domain Containing 3, IL interleukin, Cas-1 caspase 1, TLR9 toll-like receptor 9, MyD88 myeloid differentiation primary response 88, cGAS cyclic GMP–AMP synthase, cGAMP cyclic guanosine monophosphate–adenosine, STING stimulator of interferon genes, IRF3 interferon regulatory factor 3. Figure created with BioRender (http://www.BioRender.com)CC BY · PubMed Central
Fig. 3 Crosstalk between non-parenchymal and surrounding immunological cells in NASH. LSEC liver sinusoidal endothelial cells, NK natural killer, NKT natural killer T, HSC hepatic stellate cell, DAMPs damage-associated molecular pattern. Figure created with BioRender (http://www.BioRender.com)
Fig. 3 Crosstalk between non-parenchymal and surrounding immunological cells in NASH. LSEC liver sinusoidal endothelial cells, NK natural killer, NKT natural killer T, HSC hepatic stellate cell, DAMPs damage-associated molecular pattern. Figure created with BioRender (http://www.BioRender.com)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 128 references

Cited by

See all 61

Metadata

Authors
Myint, M., Oppedisano, F., De Giorgi, V., Kim, B.-M., Marincola, F. M., Alter, H. J., & Nesci, S.
Affiliations
  • Magna Graecia University (IT)
  • National Institutes of Health (US)
  • University of Bologna (IT)
Corresponding author
Nesci, Salvatore
Venue
Journal of Translational Medicine
Published
2023-10-26
Volume
21
Issue
1
Pages
757-757
ISSN
1479-5876 (ISSN-L)
OpenAlex
W4387966562
Cited by
61
References
128
Citations by year
2026: 22 · 2025: 19 · 2024: 19 · 2023: 1
FWCI
2.37
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Translational Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
nonalcoholic steatohepatitis, mitochondrial dysfunction, hepatocytes, liver inflammation, liver fibrosis, oxidative stress, lipotoxicity, oxidative phosphorylation, mitochondrial reactive oxygen species, damage-associated molecular patterns, Kupffer cells, hepatic stellate cells, innate immunity, steatosis
MeSH terms
Fibrosis, Humans, Inflammation, Liver, Mitochondria, Hepatocytes, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions. https://app.cochat.ai/papers/10.1186/s12967-023-04627-0
The paper
Myint, M., Oppedisano, F., De Giorgi, V., Kim, B.-M., Marincola, F. M., Alter, H. J., & Nesci, S. (2023). Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions. Journal of Translational Medicine. https://doi.org/10.1186/s12967-023-04627-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.